Base year

Ended Definitive Contract Awarded Last action

Contract number
HDTRA113C0011
Awardee
Awarding agency
Obligated
$10,324,851

Award facts

Contract value 96% obligated
  • $10,475,767.72 Current, with exercised options
  • $10,779,939.95 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Orlando, FL 32826, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00014 · Optimize and utilize the mimic system to provide an accurate immunological assessment of biodefense vaccine candidates in humans. $0
Supplemental Agreement for work within scope P00013 · NCE option period 3 $353,408
Funding Only Action P00012 · Base year - AD92 -$353,408
Supplemental Agreement for work within scope P00011 · Option period 3 exercise $900,000
Supplemental Agreement for work within scope P00010 · 60-day NCE $0
Supplemental Agreement for work within scope P00009 · Add task to SOW - AD92 $285,944
Supplemental Agreement for work within scope P00008 · Predictive in vitro models to assess biodefense vaccines -- incorporate revised SOW $0
Exercise an Option P00007 · Predictive in vitro models to assess biodefense vaccines -- option year 2 (PSC code: AD92) $1,496,358
Supplemental Agreement for work within scope P00006 $0
Change Order P00005 · Predictive in vitro models to assess biodefense vaccines (PSC code: AD92) OP #1 $0
Supplemental Agreement for work within scope P00004 -$200,000
Exercise an Option P00003 · Option I - AD92 $3,861,068
Change Order P00002 $0
Change Order P00001 $2,575,291
Original award $1,406,191
Show all 15

About this award

Written by GovTribe AI ·

This is a federal contract award from the Defense Threat Reduction Agency (DTRA), a defense agency, to Sanofi Pasteur Vaxdesign Corp, a for-profit foreign-owned organization. The contract is a Cost Plus Fixed Fee Definitive Contract with a ceiling value of $10,779,939.95 and an ultimate completion date of March 24, 2018. The contract was awarded on March 21, 2013 and does not have a set-aside designation. The contract is for the BASE YEAR, indicating it may be part of a larger contract vehicle. Without additional details on the original solicitation, the specific products or services being delivered under this contract are unclear, but the agency's mission suggests it is likely related to defense threat reduction capabilities.

Quick answers

Who was awarded contract HDTRA113C0011?

HDTRA113C0011 was awarded to Sanofi Pasteur Vaxdesign Corp by Defense Threat Reduction Agency (Department of Defense) on March 21, 2013.

How much is contract HDTRA113C0011 worth?

The government has obligated $10,324,851 on HDTRA113C0011. Its current value, with exercised options, is $10,475,768. Its potential value, with all options, is $10,779,940.

Was contract HDTRA113C0011 competed?

The extent of competition for HDTRA113C0011 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login